Dr. Girgrah is the Chief Wellness Officer at Ochsner Health. He leads the efforts of the Office of Professional Well-Being (OPW) at Ochsner Health which is charged with improving the professional fulfillment of their employed physicians and healthcare workforce focusing on enhanced practice efficiency and personal and team resilience and building an organizational culture that promotes provider well-being. Dr. Girgrah received both his medical degree and Ph.D. from the University of Toronto.

JO SHAPIRO, MD, FACS, is an associate professor of Otolaryngology-Head and Neck Surgery at Harvard Medical School and a consultant for the Department of Surgery at Massachusetts General Hospital. In 2008, she founded the Brigham and Women's Hospital Center for Professionalism and Peer Support, where she served as the director for over 10 years. In 2018, Harvard Medical School gave her the Shirley Driscoll Dean's Award for the Advancement of Women's Careers.

Michele Tana is a gastroenterologist and hepatologist at Zuckerberg San Francisco General Hospital and Associate Professor of Medicine at UCSF. She is the Principal Investigator for Prospective Observational Study to Understand Liver Diseases (POSULD), she co-founded the North American Alliance for Autoimmune Hepatitis, and her research focuses on health equity.

I am a Clinical Professor of Medicine at Tulane School of Medicine where I specialize in the management of complications of end stage liver disease

Dr Jennifer Guy MD MAS is a transplant hepatologist and Director of the Liver Cancer Program at California Pacific Medical Center. She is the Kranzusch Bosworth Endowed Chair for Innovation in Transplant Medicine with a focus on optimizing the patient experience.

Sidney Zisook, M.D. is a University of California San Diego (UCSD) Distinguished Professor of Psychiatry. He completed medical school at the Stitch-Loyola School of Medicine, residency at Massachusetts General Hospital and a clinical fellowship in psychiatry at Harvard University. As co-founder of the San Diego Chapter of American Foundation for Suicide Prevention (AFSP) in 2007, he launched and co-led a healthcare team suicide prevention program, the Healer Education, Assessment and Referral (HEAR ) program, for the UC San Diego medical school and health science community.

Melissa Zuckerman, MS, is the Chief Experience Officer (CXO) at the Dr. Lorna Breen Heroes' Foundation. As CXO, she brings engagements to life with clear vision and partnership – driving a unified approach to improve health workers' wellbeing and mental health. Prior to joining the Foundation, Melissa co-led JPA Health's public health practice in supporting nonprofit organizations, foundations, and professional associations in effectively engaging people and communities in public health education, healthcare professional support, and community involvement.

Dr. Vargas is a Mayo Clinic Consultant in the Department of Gastroenterology and Hepatology and the Mayo Clinic Transplantation Center. He is a Professor of Medicine in the Mayo Clinic Alix School of Medicine, where he is the Director for Research and a Associate Director for Medical School Affairs for the MD/PhD program in the Mayo Clinic Graduate School of Biomedical Sciences.<br>Dr. Vargas has authored or coauthored more than 190 peer-reviewed articles. He is a Fellow of the AASLD, AGA, ACG, ASGE and ACP.

Batuhan Yenilmez is an Assistant Professor at the University of Massachusetts Chan Medical School, where he leads a research program focused on developing next-generation RNA interference (RNAi)-based therapeutics in collaboration with world-renowned RNA chemists under the UMass Chan umbrella. His lab investigates metabolic and fibrotic diseases, with a particular emphasis on obesity, type 2 diabetes, metabolic dysfunction-associated steatohepatitis (MASH), and pulmonary fibrosis. By engineering tissue-selective RNAi molecules and exploring anti-fibrotic microRNAs, Dr.

Dr. Marshall Padilla received his PhD in Chemistry at the University of Wisconsin-Madison and is now an NIH Postdoctoral Fellow at the University of Pennsylvania's Department of Bioengineering in the Mitchell Lab. Dr. Padilla focuses on utilizing synthesis and biophysics to deeply characterize and rationally design lipid nanoparticles. He applies this knowledge to develop next-generation lipid nanoparticles for liver gene editing and cancer therapy, the latter through an NIH T90 fellowship.